Citations (54)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
William David Wells-Gatnik, Tiffany Yazmin Wences Chirino, Fatma Nur Onan, Dilara Onan & Paolo Martelletti. (2023) Emerging experimental drugs in clinical trials for migraine: observations and key talking points. Expert Opinion on Investigational Drugs 32:8, pages 761-771.
Read now
Read now
Andrea Negro & Paolo Martelletti. (2021) Novel synthetic treatment options for migraine. Expert Opinion on Pharmacotherapy 22:7, pages 907-922.
Read now
Read now
Martina Curto, Fabiola Cipolla, Giusy Ylenia Cisale, Matilde Capi, Valerio Spuntarelli, Martina Guglielmetti, Paolo Martelletti & Luana Lionetto. (2020) Profiling lasmiditan as a treatment option for migraine. Expert Opinion on Pharmacotherapy 21:2, pages 147-153.
Read now
Read now
Andrea Negro & Paolo Martelletti. (2019) Patient selection for migraine preventive treatment with anti-CGRP(r) monoclonal antibodies. Expert Review of Neurotherapeutics 19:8, pages 769-776.
Read now
Read now
Andrea Negro & Paolo Martelletti. (2019) Gepants for the treatment of migraine. Expert Opinion on Investigational Drugs 28:6, pages 555-567.
Read now
Read now
Paolo Martelletti & Maria Adele Giamberardino. (2019) Advances in orally administered pharmacotherapy for the treatment of migraine. Expert Opinion on Pharmacotherapy 20:2, pages 209-218.
Read now
Read now
Jessica C Oswald & Nathaniel M Schuster. (2018) Lasmiditan for the treatment of acute migraine: a review and potential role in clinical practice. Journal of Pain Research 11, pages 2221-2227.
Read now
Read now
Articles from other publishers (47)
Cinder Faith Cohen, Jueun Roh, Sang Hoon Lee, Chul-Kyu Park & Temugin Berta. (2023) Targeting Nociceptive Neurons and Transient Receptor Potential Channels for the Treatment of Migraine. International Journal of Molecular Sciences 24:9, pages 7897.
Crossref
Crossref
Surajpal Verma, Rajiv Kumar Tonk, Mohammed Albratty, Hassan Ahmad Alhazmi, Asim Najmi, Ravi Kumar, Mohit Kumar, Mohamad Taleuzzaman, Gourav Swami & Md Shamsher Alam. (2022) Design and evaluation of sustained release mucoadhesive film of sumatriptan succinate containing grafted co-polymer as the platform. Saudi Pharmaceutical Journal 30:11, pages 1527-1537.
Crossref
Crossref
Ana Claudia Sueiro, Érica Mendes dos Santos, Louise Lacalendola Tundisi, Ana Laura Masquetti Fava, Luiza Aparecida Luna Silvério, Julia Cedran Coco, Janaína Artem Ataide, Ana Cláudia Paiva-Santos & Priscila Gava Mazzola. (2022) Transdermal delivery systems for migraine treatment: A gap to explore. Journal of Drug Delivery Science and Technology 77, pages 103919.
Crossref
Crossref
Michael T. Li, Christopher Louis Robinson, Qing Zhao Ruan, Sindhuja Surapaneni & Warren Southerland. (2022) The Influence of Sleep Disturbance on Chronic Pain. Current Pain and Headache Reports 26:10, pages 795-804.
Crossref
Crossref
Roger Gregory Biringer. (2022) Migraine signaling pathways: amino acid metabolites that regulate migraine and predispose migraineurs to headache. Molecular and Cellular Biochemistry 477:9, pages 2269-2296.
Crossref
Crossref
Mahsa Pourhamzeh, Fahimeh Ghasemi Moravej, Mehrnoosh Arabi, Elahe Shahriari, Soraya Mehrabi, Richard Ward, Reza Ahadi & Mohammad Taghi Joghataei. (2021) The Roles of Serotonin in Neuropsychiatric Disorders. Cellular and Molecular Neurobiology 42:6, pages 1671-1692.
Crossref
Crossref
John H. Krege, Richard B. Lipton, Simin K. Baygani, Mika Komori, Sinéad M. Ryan & Maurice Vincent. (2022) Lasmiditan for Patients with Migraine and Contraindications to Triptans: A Post Hoc Analysis. Pain and Therapy 11:2, pages 701-712.
Crossref
Crossref
Alfredo Munoz, Christina Maxwell, Natalie Gofman, Kenneth Liebman & Erol Veznedaroglu. (2022) The management of trigeminal neuralgia with triptans, a narrative review of the literature. Headache: The Journal of Head and Face Pain 62:5, pages 543-547.
Crossref
Crossref
Darko Katalinic, Aleksandar Vcev, Martina Smolic & Ivan Aleric. (2022) Serotonin receptor agonists in the treatment of migraine: A meta-analysis considering possible connection with paresthesia. Annals of Indian Academy of Neurology 25:3, pages 332.
Crossref
Crossref
Oliver Clark, Areej Mahjoub, Nily Osman, Ann-Marie Surmava, Saber Jan & Ana Marissa Lagman-Bartolome. (2021) Non-invasive neuromodulation in the acute treatment of migraine: a systematic review and meta-analysis of randomized controlled trials. Neurological Sciences 43:1, pages 153-165.
Crossref
Crossref
Cansel Kose Ozkan, Ozgur Esim & Ayhan Savaser. 2022. Nanomaterials for Cancer Detection Using Imaging Techniques and Their Clinical Applications. Nanomaterials for Cancer Detection Using Imaging Techniques and Their Clinical Applications
115
139
.
Eduardo Rivera-Mancilla & Antoinette MaassenVanDenBrink. 2022. Novel Synthetic Drugs in Migraine. Novel Synthetic Drugs in Migraine
1
17
.
Andrew Blumenfeld, Paul L. Durham, Alexander Feoktistov, Debbie L. Hay, Andrew F. Russo & Ira Turner. (2021) Hypervigilance, Allostatic Load, and Migraine Prevention: Antibodies to CGRP or Receptor. Neurology and Therapy 10:2, pages 469-497.
Crossref
Crossref
Rituparna Maiti, Archana Mishra, Haridas Mundot Puliappadamb, Monalisa Jena & Anand Srinivasan. (2021) Efficacy and Safety of Lasmiditan for Acute Treatment of Migraine in Adults: A Meta‐Analysis. The Journal of Clinical Pharmacology 61:12, pages 1534-1544.
Crossref
Crossref
Jae Hyun Lee, Anand R. Shewale, Douglas Barthold & Beth Devine. (2021) Geographic variation in the use of triptans and opioids for the acute treatment of migraine attacks. Headache: The Journal of Head and Face Pain 61:10, pages 1499-1510.
Crossref
Crossref
Moein Ala, Mehdi Ghasemi, Razieh Mohammad Jafari & Ahmad Reza Dehpour. (2021)
Beyond its
anti‐migraine
properties, sumatriptan is an
anti‐inflammatory
agent: A systematic review
. Drug Development Research 82:7, pages 896-906.
Crossref
Crossref
Ping Gu, Cheng Chen, Qian Wu, Changhong Dong, Teng Wang, Qi Wan & Xin Dong. (2021) The Effect and Safety of 5-HT1F Receptor Agonist Lasmiditan on Migraine: A Systematic Review and Meta-Analysis. BioMed Research International 2021, pages 1-14.
Crossref
Crossref
Juliana K Beauchene & Terri L Levien. (2021) Lasmiditan: Acute Migraine Treatment Without Vasoconstriction. A Review. Journal of Pharmacy Technology 37:5, pages 244-253.
Crossref
Crossref
Damiana Scuteri & Giacinto Bagetta. (2021) Progress in the Treatment of Migraine Attacks: From Traditional Approaches to Eptinezumab. Pharmaceuticals 14:9, pages 924.
Crossref
Crossref
Paul A DeJulio, Joshua K Perese, Nathaniel M Schuster & Jessica C Oswald. (2021) Lasmiditan for the acute treatment of migraine. Pain Management 11:5, pages 437-449.
Crossref
Crossref
Sijie Huang, Peiyu Xu, Yangxia Tan, Chongzhao You, Yumu Zhang, Yi Jiang & H. Eric Xu. (2021) Structural basis for recognition of anti-migraine drug lasmiditan by the serotonin receptor 5-HT1F–G protein complex. Cell Research 31:9, pages 1036-1038.
Crossref
Crossref
Johra Khan, Lubna Ibrahim Al Asoom, Ahmad Al Sunni, Nazish Rafique, Rabia Latif, Seham Al Saif, Noor B. Almandil, Dana Almohazey, Sayed AbdulAzeez & J. Francis Borgio. (2021) Genetics, pathophysiology, diagnosis, treatment, management, and prevention of migraine. Biomedicine & Pharmacotherapy 139, pages 111557.
Crossref
Crossref
Himanshu Suri & Jessica Ailani. (2021) Cluster Headache: A Review and Update in Treatment. Current Neurology and Neuroscience Reports 21:7.
Crossref
Crossref
Linda Al-Hassany & Antoinette MaassenVanDenBrink. (2021) Drug interactions and risks associated with the use of triptans, ditans and monoclonal antibodies in migraine. Current Opinion in Neurology 34:3, pages 330-338.
Crossref
Crossref
Hemme J. Hijma & Geert Jan Groeneveld. (2021) Analgesic drug development: proof-of-mechanism and proof-of-concept in early phase clinical studies. Medicine in Drug Discovery 10, pages 100083.
Crossref
Crossref
Anroop B. Nair, Jigar Shah, Shery Jacob, Bandar E. Al-Dhubiab, Vimal Patel, Nagaraja Sreeharsha & Pottathil Shinu. (2021) Development of Mucoadhesive Buccal Film for Rizatriptan: In Vitro and In Vivo Evaluation. Pharmaceutics 13:5, pages 728.
Crossref
Crossref
Tahira Farooqui. 2021. Gut Microbiota in Neurologic and Visceral Diseases. Gut Microbiota in Neurologic and Visceral Diseases
267
286
.
Jennifer Wu, Pranamya Suri, Danielle Perret Karimi & Bi-Ying Yeh. 2021. Migraine. Migraine
29
49
.
Flavianny Braga Barbosa De Oliveira, Francisco Diogo Almeida Silva, George Icaro Maia Farias, Ialy Beatriz Lima Ferreira, Jéssika Jannyne Gomes De Lima, Maria Emília Matos Pequeno Dias & Francisco José Batista de Lima Júnior. (2020) Anticorpos monoclonais para o tratamento de enxaqueca (migrânea). Revista Neurociências 28, pages 1-20.
Crossref
Crossref
I. Liampas, V. Siokas, A. Brotis & E. Dardiotis. (2020) Vitamin D serum levels in patients with migraine: A meta-analysis. Revue Neurologique 176:7-8, pages 560-570.
Crossref
Crossref
Mika KOMORI, Hanaka MIMURA, Max TSAI, Akichika OZEKI, Go TAKAICHI & Darren WILBRAHAM. (2020) Safety, Tolerability, and Pharmacokinetics of Lasmiditan in Healthy Japanese and Caucasian Subjects. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics 51:3, pages 119-127.
Crossref
Crossref
Rajagopalan Vijayaraghavan. (2020) Autoinjector device for rapid administration of drugs and antidotes in emergency situations and in mass casualty management. Journal of International Medical Research 48:5, pages 030006052092601.
Crossref
Crossref
Claudia Sorbi, Annalisa Tait, Umberto M. Battisti & Livio Brasili. (2020) Spiroxatrine derivatives towards 5-HT1A receptor selectivity. Pharmacological Reports 72:2, pages 427-434.
Crossref
Crossref
Damiana Scuteri, Annagrazia Adornetto, Laura Rombolà, MariaDiana Naturale, AdeleEmanuela De Francesco, Stefania Esposito, Mariacristina Zito, LuigiAntonio Morrone, Giacinto Bagetta, Paolo Tonin & MariaTiziana Corasaniti. (2020) Pattern of triptans use: a retrospective prescription study in Calabria, Italy. Neural Regeneration Research 15:7, pages 1340.
Crossref
Crossref
Damiana Scuteri, Annagrazia Adornetto, Laura Rombolà, MariaDiana Naturale, AdeleEmanuela De Francesco, Stefania Esposito, Mariacristina Zito, LuigiAntonio Morrone, Giacinto Bagetta, Paolo Tonin & MariaTiziana Corasaniti. (2020) Pattern of triptans use: a retrospective prescription study in Calabria, Italy. Neural Regeneration Research 15:3, pages 1340.
Crossref
Crossref
Volker Neugebauer. 2020. Handbook of the Behavioral Neurobiology of Serotonin. Handbook of the Behavioral Neurobiology of Serotonin
309
320
.
Zhuo-Ying Tao, Pei-Xing Wang, Si-Qi Wei, Richard J. Traub, Jin-Feng Li & Dong-Yuan Cao. (2019) The Role of Descending Pain Modulation in Chronic Primary Pain: Potential Application of Drugs Targeting Serotonergic System. Neural Plasticity 2019, pages 1-16.
Crossref
Crossref
Andrea Negro, Paolo Sciattella, Daniele Rossi, Martina Guglielmetti, Paolo Martelletti & Francesco Saverio Mennini. (2019) Cost of chronic and episodic migraine patients in continuous treatment for two years in a tertiary level headache Centre. The Journal of Headache and Pain 20:1.
Crossref
Crossref
Willem Sebastiaan van Hoogstraten & Antoinette MaassenVanDenBrink. (2019) The need for new acutely acting antimigraine drugs: moving safely outside acute medication overuse. The Journal of Headache and Pain 20:1.
Crossref
Crossref
Irene Wood, Lucas Fabian, Albertina Moglioni, Luis Fernando Cabeça, Eneida de Paula & Mónica Pickholz. (2019) Combining nuclear magnetic resonance with molecular dynamics simulations to address sumatriptan interaction with model membranes. Chemistry and Physics of Lipids 225, pages 104792.
Crossref
Crossref
Jan Lewis Brandes, Suzanne Klise, John H Krege, Michael Case, Rashna Khanna, Raghavendra Vasudeva, Joel Raskin, Eric M Pearlman & David Kudrow. (2019) Interim results of a prospective, randomized, open-label, Phase 3 study of the long-term safety and efficacy of lasmiditan for acute treatment of migraine (the GLADIATOR study). Cephalalgia 39:11, pages 1343-1357.
Crossref
Crossref
Guangchen Ji & Volker Neugebauer. (2019) Contribution of Corticotropin-Releasing Factor Receptor 1 (CRF1) to Serotonin Receptor 5-HT2CR Function in Amygdala Neurons in a Neuropathic Pain Model. International Journal of Molecular Sciences 20:18, pages 4380.
Crossref
Crossref
Yu Wang, Yajun Shi, Xiaofei Zhang, Junbo Zou, Yulin Liang, Jia Tai, Mei Wang, Chunli Cui & Dongyan Guo. (2019) A Chinese Prescription Chuanxiong Chatiao San for Migraine: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Evidence-Based Complementary and Alternative Medicine 2019, pages 1-17.
Crossref
Crossref
Carey D. Balaban, Robert D. Black & Stephen D. Silberstein. (2019) Vestibular Neuroscience for the Headache Specialist. Headache: The Journal of Head and Face Pain 59:7, pages 1109-1127.
Crossref
Crossref
Sha Wu, Li Guo, Feng Qiu & Muxin Gong. (2019) Anti-Migraine Effect of the Herbal Combination of Chuanxiong Rhizoma and Cyperi Rhizoma and UPLC-MS/MS Method for the Simultaneous Quantification of the Active Constituents in Rat Serum and Cerebral Cortex. Molecules 24:12, pages 2230.
Crossref
Crossref
Paolo Martelletti, Piero Barbanti, Licia Grazzi, Giulia Pierangeli, Innocenzo Rainero, Pierangelo Geppetti, Anna Ambrosini, Paola Sarchielli, Cristina Tassorelli, Eric Liebler & Marina de Tommaso. (2018) Consistent effects of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: additional findings from the randomized, sham-controlled, double-blind PRESTO trial. The Journal of Headache and Pain 19:1.
Crossref
Crossref
Kate W. Grimsrud & Rashmi B. Halker Singh. (2018) Emerging Treatments in Episodic Migraine. Current Pain and Headache Reports 22:9.
Crossref
Crossref